Wellgistics Health (NASDAQ:WGRX - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued on Friday.
Wellgistics Health Price Performance
WGRX stock traded up $0.09 during midday trading on Friday, hitting $1.01. The company's stock had a trading volume of 32,744,838 shares, compared to its average volume of 262,477. The company has a debt-to-equity ratio of 1.43, a quick ratio of 0.15 and a current ratio of 0.36. Wellgistics Health has a 12 month low of $0.75 and a 12 month high of $7.04.
Wellgistics Health Company Profile
(
Get Free Report)
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
Featured Articles
Before you consider Wellgistics Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Wellgistics Health wasn't on the list.
While Wellgistics Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
